These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 11286732)
61. TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease. Lewinsohn DM; Lewinsohn DA; Grotzke JE Semin Respir Infect; 2003 Dec; 18(4):320-38. PubMed ID: 14679479 [TBL] [Abstract][Full Text] [Related]
62. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting. Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009 [TBL] [Abstract][Full Text] [Related]
63. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model. Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898 [TBL] [Abstract][Full Text] [Related]
64. Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model. Rao M; Cadieux N; Fitzpatrick M; Reed S; Arsenian S; Valentini D; Parida S; Dodoo E; Zumla A; Maeurer M Int J Infect Dis; 2017 Mar; 56():274-282. PubMed ID: 28161464 [TBL] [Abstract][Full Text] [Related]
65. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice. Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571 [TBL] [Abstract][Full Text] [Related]
66. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis. Xing Z; Charters TJ Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008 [TBL] [Abstract][Full Text] [Related]
67. Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine. Lee JW; Parlane NA; Rehm BHA; Buddle BM; Heiser A Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 28087528 [TBL] [Abstract][Full Text] [Related]
68. Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. Huang D; Qiu L; Wang R; Lai X; Du G; Seghal P; Shen Y; Shao L; Halliday L; Fortman J; Shen L; Letvin NL; Chen ZW J Infect Dis; 2007 Jan; 195(1):55-69. PubMed ID: 17152009 [TBL] [Abstract][Full Text] [Related]
69. Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection. Zhang M; Dong C; Xiong S Hum Vaccin Immunother; 2017 Apr; 13(4):816-822. PubMed ID: 27960596 [TBL] [Abstract][Full Text] [Related]
70. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen. Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261 [TBL] [Abstract][Full Text] [Related]
71. Tuberculosis vaccine development at a divide. Kaufmann SH Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237 [TBL] [Abstract][Full Text] [Related]
72. Strategies for developing tuberculosis vaccines: emerging approaches. Mollica A; Stefanucci A; Costante R Curr Drug Targets; 2013 Aug; 14(9):938-51. PubMed ID: 23469877 [TBL] [Abstract][Full Text] [Related]